Home > Healthcare > Mobile Gamma Cameras Market
Mobile Gamma Cameras Market Size
Mobile Gamma Cameras Market size will register significant growth between 2024 and 2032, driven by growing research and development efforts in cancer diagnosis. With cancer prevalence on the rise, there's a pressing need for advanced diagnostic tools that offer mobility and versatility.
For instance, in March 2021, Scientists engineered a portable 3D imaging device to enhance cancer treatment and diagnosis. Handheld gamma imaging tools offer convenience, but they are limited to providing 2D information, and larger systems provide 3D images but are cumbersome and space-consuming. Researchers at Loughborough University devised the Hybrid Gamma Camera (HGC), merging the advantages of both devices. Lead author Dr. Sarah Bugby, from the School of Science, spearheaded the development of this device, which is compact and portable, akin to a hairdryer, facilitating easy transportation to any required location.
Mobile gamma cameras fill this gap by providing on-the-go imaging solutions for early detection and accurate staging of cancer. As research continues to enhance the sensitivity and specificity of these devices, their demand could soar, revolutionizing cancer diagnosis and management globally.
The mobile gamma cameras market is experiencing heightened demand due to increasing investments from hospitals in these devices. Recognizing the importance of on-the-go imaging solutions, hospitals are allocating resources to acquire mobile gamma cameras. These devices offer flexibility and versatility in diagnostic imaging, enabling healthcare professionals to conduct scans conveniently at the point of care. With a focus on enhancing patient care and efficiency, hospitals are prioritizing the adoption of mobile gamma cameras.
In February 2024, a new mobile gamma camera designed for detecting cancer, pediatric conditions, and other acute illnesses was introduced as part of a £3.6 million project within hospital premises managed by The Shrewsbury and Telford Hospital NHS Trust (SaTH). The expected benefits of the camera include improved image quality, faster report issuance, reduced scanning durations, and increased patient throughput. The advanced equipment is also anticipated to attract skilled staff and enhance workforce retention within the Trust.
Despite its growing demand, the mobile gamma cameras market faces several restraints. Challenges include the high cost associated with acquiring and maintaining mobile gamma cameras, making them inaccessible to some healthcare facilities. Additionally, concerns regarding radiation exposure and safety protocols may hinder widespread adoption. Limited portability and imaging capabilities compared to traditional gamma cameras pose further limitations. Moreover, regulatory requirements and reimbursement policies can impact market expansion. Addressing these restraints necessitates technological advancements, cost-effective solutions, and regulatory support to unlock the full potential of mobile gamma cameras.
Mobile Gamma Cameras Market Trends
The industry is witnessing significant trends driven by a surge in product launches from leading companies. As healthcare demands evolve, industry leaders are introducing innovative mobile gamma camera solutions to address emerging needs. These new products boast enhanced portability, imaging capabilities, and user-friendly features, catering to the growing demand for on-the-go diagnostic solutions. With a focus on improving patient care and workflow efficiency, these product launches are reshaping the landscape of the industry.
For instance, in June 2023, after undergoing clinical testing in the United States, a UK-based Serac Imaging Systems developed a transportable high-resolution hybrid gamma optical camera and entered a six-month study involving 25 patients. The Ohio State University Wexner Medical Center became the second site to initiate an investigator-sponsored study, after previous testing in Kuala Lumpur, Malaysia. This study aimed to compare the current advanced gamma camera for medical imaging with gamma images obtained using Seracam, all acquired from the same patient on the same day. Originally designed for satellites in X-ray astronomy by the University of Leicester, the device employs radiation to image radioisotopes administered to patients, revealing crucial information about bodily functions such as identifying blockages.
Mobile Gamma Cameras Market Analysis
Considering application, the breast imaging segment will amass considerable profits by 2032. Growth from this segment is due to the growing elderly population and the escalating prevalence of cancer among the burgeoning number of obese people worldwide. According to the CDC, above 90% of new obesity-related cancers are diagnosed among men and women aged 50 years and above, thus augmenting the need for mobile gamma camera equipment. Based on end-user, the ambulatory surgical centers segment will register an appreciable revenue over the estimated timeline. This can be credited to the myriad advantages of treatment at ASCs over hospitals, including low costs and reduced risks of infection.
Asia Pacific mobile gamma cameras market is poised to depict a high growth rate through 2032, owing to the surging cases of pancreatic cancer in emerging economies such as India. Given the significant application scope of nuclear medicine in the treatment of aggressive tumors like pancreatic adenocarcinoma, the rising disease incidence will drive the regional market share. Likewise, the considerable increase in healthcare spending, in line with the high burden of cardiac diseases among urban patients in China, will also accentuate the demand for mobile gamma cameras in the upcoming years.
Mobile Gamma Cameras Market Share
Major companies operating in the mobile gamma cameras industry competitive landscape include:
- Spectrum Dynamics Medical (Biosensors International)
- Dilon Technologies
- Beijing Hamamatsu Photon Techniques
- GAEDE Medizinsysteme
- Digirad Corporation
- DDD-Diagnostic A/S
Mobile Gamma Cameras Industry News
In April 2021, Star Equity Holdings, a diversified holding company comprising three divisions: Healthcare, Construction, and Investments, announced the successful sale completion of DMS Health Technologies, Inc., its Mobile Healthcare business, for $18.75 million in cash. The CEO of Digirad Health, Inc. stated, "With the divestment of DMS Health and another minor asset sale, totaling $1.4 million, we've optimized our healthcare portfolio. We now concentrate on higher-margin segments, lower capex within our Healthcare division. Our sales team is dedicated to exploring new opportunities to expand our client base and geographic footprint for marketing and servicing our Digirad branded solid-state imaging cameras and on-site camera rental services.